Kevin Draves

Title: Kevin Draves: Innovator in Immunology

Introduction

Kevin Draves is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of immunology through his innovative research and patented inventions. His work focuses on dendritic cell-associated lectin-like molecules, which have important implications for therapeutic methods in immune response stimulation.

Latest Patents

Kevin Draves holds a patent for "Dendritic cell-associated lectin-like molecules, compositions and methods of use." This invention provides novel dendritic cell-associated lectin-like (DCAL-1) molecules, compositions, and therapeutic methods of use. The patent includes isolated nucleic acid molecules capable of remaining hybridized to specific sequences, as well as DCAL-1 polypeptides that are useful for stimulating T cell proliferation. Additionally, the invention encompasses antibodies that specifically bind to DCAL-1, promoting the maturation of dendritic cells and stimulating an immune response in vivo. Methods for stimulating an immune response in animals using anti-DCAL-1 antibodies are also detailed in the patent.

Career Highlights

Kevin Draves is affiliated with the University of Washington, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in therapeutic settings, particularly in enhancing immune responses.

Collaborations

Kevin has collaborated with esteemed colleagues, including Edward A Clark and Elizabeth Ryan, contributing to a rich environment of innovation and research.

Conclusion

Kevin Draves is a prominent figure in the field of immunology, with a focus on dendritic cell-associated lectin-like molecules. His patented inventions hold promise for advancing therapeutic methods in immune response stimulation.